Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sungyong You
Affiliation
Cedars-Sinai Medical Center
ORCID
Career Start Year
2008
Papers
110
H Index
30
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37604982
Bioinformatics in urology - molecular characterization of pathophysiology and response to treatment.
Nat Rev Urol
2024
35908246
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Hepatology
2023
37562753
Complement C1q essential for aeroallergen sensitization via CSF1R<sup>+</sup> conventional dendritic cells type 2.
J Allergy Clin Immunol
2023
37905039
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.
bioRxiv
2023
37484909
Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated region.
Front Cell Dev Biol
2023
37172577
Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment.
Cell Metab
2023
37066364
Aging gene signature of IL-7 receptor alpha low effector memory CD8<sup>+</sup> T cells is associated with neurocognitive functioning in Alzheimer's disease.
Res Sq
2023
36509363
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration.
Cancer Lett
2023
36711067
Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs.
Nano Today
2023
36045587
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Mol Ther
2023
34450249
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.
Mol Ther
2022
35543075
Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma.
J Gastroenterol Hepatol
2022
35638091
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.
Eur Urol Open Sci
2022
35519421
Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology.
IEEE Open J Eng Med Biol
2022
35618577
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.
Urol Oncol
2022
36636695
Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer.
Am J Clin Exp Urol
2022
35902588
Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Nat Commun
2022
36161213
Hepatocellular carcinoma surveillance: current practice and future directions.
Hepatoma Res
2022
35918812
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.
J Natl Cancer Inst
2022
35973929
Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
Urol Oncol
2022
35124841
Early detection of primary liver cancer using plasma cell-free DNA fragmentomics: Do all the pieces come together?
Hepatology
2022
35115556
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Nat Commun
2022
34897998
BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
Proteomics
2022
35078507
KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
Breast Cancer Res
2022
34818445
NUAK family kinase 2 is a novel therapeutic target for prostate cancer.
Mol Carcinog
2022
34728526
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.
Clin Cancer Res
2022
34664394
Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
Liver Transpl
2022
33037017
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Clin Cancer Res
2021
33649313
TMPRSS2 activity may mediate sex differences in COVID-19 severity.
Signal Transduct Target Ther
2021
33531653
A comparative study of PCS and PAM50 prostate cancer classification schemes.
Prostate Cancer Prostatic Dis
2021
34948334
On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances.
Int J Mol Sci
2021
34427305
Stromal androgen and hedgehog signaling regulates stem cell niches in pubertal prostate development.
Development
2021
34400895
Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology.
Int J Med Sci
2021
34541033
Loss of CDCP1 triggers FAK activation in detached prostate cancer cells.
Am J Clin Exp Urol
2021
34541032
Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer.
Am J Clin Exp Urol
2021
34329585
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.
Cancer Cell
2021
34212072
Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.
Adv Mater Technol
2021
34203086
The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.
Cancers (Basel)
2021
33362108
Microscope calibration protocol for single-molecule microscopy.
Opt Express
2021
32252184
Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects.
Int Neurourol J
2020
31844180
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
Prostate Cancer Prostatic Dis
2020
32019810
27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Mol Cancer Res
2020
33055242
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.
Sci Transl Med
2020
32944167
Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles.
J Extracell Vesicles
2020
33000006
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.
Eur Urol Open Sci
2020
32792852
<i>S</i>-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer.
Int J Biol Sci
2020
32619811
IL-7 receptor alpha defines heterogeneity and signature of human effector memory CD8<sup>+</sup> T cells in high dimensional analysis.
Cell Immunol
2020
32895384
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.
Nat Commun
2020
32380981
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
BMC Cancer
2020
30957416
Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism.
Proteomics
2019
1 - 50 of 110
Column Actions
Search
Recommended Authors
Rohan Bareja
Case Western Reserve University
Career Start Year
2017
Number of shared co-authors
7
Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year
2016
Number of shared co-authors
1
Mohammed Kanchwala
The University of Texas Southwestern Medical Center
Career Start Year
2016
Number of shared co-authors
2
Wei Yuan
The Institute for Cancer Research
Career Start Year
2015
Number of shared co-authors
8
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Career Start Year
2013
Number of shared co-authors
1
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
3
Anne Haegert
University of British Columbia
Career Start Year
2008
Number of shared co-authors
15
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year
2006
Number of shared co-authors
1
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year
2006
Number of shared co-authors
5
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
17
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year
2005
Number of shared co-authors
18
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
0
Jonathan Chou
University of California san francisco
Career Start Year
2005
Number of shared co-authors
16
Robert H Bell
University of British Columbia
Career Start Year
2004
Number of shared co-authors
14
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year
2003
Number of shared co-authors
4
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
1
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year
2003
Number of shared co-authors
3
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
12
Ladan Fazli
University of British Columbia
Career Start Year
2002
Number of shared co-authors
26
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
13
Habib Hamidi
Genentech Inc.
Career Start Year
2002
Number of shared co-authors
0
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
4
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
1
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
1
Robert Kim
University of California
Career Start Year
1996
Number of shared co-authors
5
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year
1993
Number of shared co-authors
32
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
6
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
13
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
24
row(s) 1 - 30 of 30
Collaborators
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
38
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Co-authored papers
23
Daehee Hwang
Co-authored papers
20
Edwin M Posadas
Cedars-Sinai Medical Center
Co-authored papers
15
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers
14
Dolores Di Vizio
Cedars-Sinai Medical Center
Co-authored papers
13
Hsian-Rong Tseng
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers
11
Beatrice S Knudsen
University of Utah
Co-authored papers
10
Vatche G Agopian
David Geffen School of Medicine , University of California los angeles
Co-authored papers
8
Isla P Garraway
David Geffen School of Medicine University of California Los Angeles
Co-authored papers
6
Jie-Fu Chen
Memorial Sloan Kettering Cancer Center
Co-authored papers
5
Insoo Kang
Yale School of Medicine
Co-authored papers
5
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers
5
Elai Davicioni
Veracyte Inc.
Co-authored papers
5
Steven-Huy B Han
David Geffen School of Medicine , University of California los angeles
Co-authored papers
4
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers
4
Eric A Klein
Cleveland Clinic
Co-authored papers
4
Albert C Shaw
Yale School of Medicine, Yale University
Co-authored papers
4
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers
3
Colm Morrissey
Co-authored papers
3
Yu Jen Jan
Cedars-Sinai Medical Center
Co-authored papers
3
Keith Syson Chan
Samuel Oschin Cancer Center, Cedars Sinai Medical Center
Co-authored papers
3
Yang Liu
Veracyte inc.
Co-authored papers
3
Sara Pollan
Cedars-Sinai Medical Center 8700 Beverly Blvd
Co-authored papers
3
Leigh Ellis
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
2
Subhasis Mohanty
Yale School of Medicine, Yale University
Co-authored papers
2
Eliezer Masliah
National Institute On Aging
Co-authored papers
2
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers
2
Javier Mariscal
Samuel Oschin Comprehensive Cancer Institute
Co-authored papers
2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers
2
1 - 30